Home › Ironwood starts IBS trial in China, but stock falls on analyst forecast
 

Keywords :   


Ironwood starts IBS trial in China, but stock falls on analyst forecast

2013-09-12 13:48:54| Biotech - Topix.net

Ironwood Pharmaceuticals Inc. has announced a late-stage trial in China seeking to get its irritable bowel syndrome drug approved there, but lost 4 percent of stock value after an analyst firm lowered his price target.

Tags: china stock trial falls

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
04.10Ex-Harrods exec: I lost my job due to Al Fayed
04.10How worried should I be about rising oil prices?
04.10Eastern North Pacific Tropical Weather Outlook
04.10Atlantic Tropical Weather Outlook
04.10Dont rely on technology, learn the way to a profit
04.10Targeted grazing: a successful, low-cost method to manage cheatgrass
04.10RPM General Counsel Edward W. Moore to Retire
04.10Angus Genetics Inc. gathers breeders, industry, academia in forum
More »